三諾生物(300298.SZ):取得1項醫療器械註冊證和1項醫療器械註冊變更文件
格隆匯6月30日丨三諾生物(300298.SZ)公吿,公司於近日收到湖南省藥品監督管理局頒發的一項關於智能血糖儀的《醫療器械註冊證》和一項關於便捷式全自動多功能檢測儀的《醫療器械註冊變更文件》。
上述智能血糖儀為公司新獲批的註冊證,便捷式全自動多功能檢測儀為已取得的醫療器械註冊證的變更。本次醫療器械註冊證的取得,進一步豐富了產品的種類,使之能適應更多的市場需求;醫療器械註冊證的變更,帶來產品型號規格的增加以及產品對技術要求的變更,使產品註冊證內容表述更加準確完整,
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.